Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Characterization of Polyneuropathy in Patients Receiving Enfortumab Vedotin for the Treatment of Metastatic Urothelial Carcinoma

Extended Interval Dosing of Ocrelizumab in Patients with Multiple Sclerosis Is Not Associated with Meaningful Differences in Disease Activity